Scarica l'app Stockscreener
4.965
3.12%
-0.16
Journey Medical Corp Borsa (DERM) Ultime notizie
An investment adviser reports passive ownership of 2.45M shares in Journey Medical (DERM). - Stock Titan
Fortress Biotech repays $15 million Oaktree credit facility in full By Investing.com - Investing.com India
Fortress Biotech repays $15 million Oaktree credit facility in full By Investing.com - Investing.com UK
7 Best Travel & Tourism Stocks for 2026 and How to Invest - The Motley Fool
Are Options Traders Betting on a Big Move in Journey Medical Stock? - Zacks Investment Research
Journey Medical Corporation $DERM Shares Sold by Opaleye Management Inc. - marketbeat.com
Journey Medical Corporation to Participate in September 2026 Investor Conferences - Yahoo Finance
Shinon Healthcare Receives Honors at Sanjeevani 2026 for Medical Value Travel Leadership, Advancing the 'Heal in India' Vision - indiagazette.com
Fortress Biotech's business presentation goes online Sept. 11 - Stock Titan
Nine FDA-approved skin drugs are marketed by Journey Medical. Its CEO will join two investor events. - Stock Titan
DERM 8-K FilingsJourney Medical Corporation SEC 8-K - Stock Titan
Journey Medical Corp (DERM) Key Financial Ratios – Valuation, Profitability & More - Value Research
Audubon’s Globus Medical Acquires Duke Spinout Higgs Boson Health - BioBuzz
7 Best Travel Insurance Companies of May 2026 - money.com
Journey Medical Corp (DERM) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
536,000 Shares in Journey Medical Corporation $DERM Acquired by Punch & Associates Investment Management Inc. - MarketBeat
J. Goldman & Co LP Takes Position in Journey Medical Corporation $DERM - MarketBeat
DERM | Journey Medical Corporation Common FinancialsRevenue Breakdown - Quiver Quantitative
Journey Medical: Q2 Report Confirms Thesis On Track As Emrosi Launch Gains Traction - Seeking Alpha
FY2026 EPS Estimates for Journey Medical Lowered by Analyst - MarketBeat
Teleconferência de Resultados do 2T26 da Journey Medical (FBIO): Receita cresce 23% com aceleração do Emrosi - TradingKey
Q3 EPS Estimates for Journey Medical Cut by HC Wainwright - MarketBeat
Conferencia de resultados del T2 de 2026 de Journey Medical (FBIO): los ingresos aumentan un 23% a medida que Emrosi se acelera - TradingKey
Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates - tradingkey.com
Analyst Reiterates Buy on Journey Medical as Emrosi Outperformance Supports Unchanged $13 Price Target - TipRanks
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey - The Manila Times
Journey Medical's (DERM) Buy Rating Reaffirmed at B. Riley Financial - MarketBeat
Why is Journey Medical stock rallying today? - Investing.com
Why is Journey Medical stock rallying today? By Investing.com - Investing.com Canada
Why is Journey Medical stock rallying today? By Investing.com - Investing.com UK
Why is Journey Medical stock rallying today? - Investing.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
A. G. P. Maintains Journey Medical(DERM.US) With Buy Rating, Cuts Target Price to $14 - Moomoo
Wasatch Advisors LP Buys 725,560 Shares of Journey Medical Corporation $DERM - MarketBeat
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - manilatimes.net
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewswire
Journey Medical earnings beat by $0.12, revenue topped estimates - Investing.com Canada
Journey Medical Corp (DERM) (Q2 2026) Earnings Call Highlights: Emrosi Surges 20% Sequentially, ... - Yahoo Finance
Journey Medical earnings beat by $0.12, revenue topped estimates - Investing.com Australia
DERM Looks 49.2% Overvalued on GF Value™ - GuruFocus
Journey Medical Releases Q2 2026 Financial Results - AlphaStreet
Journey Medical Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Journey Medical Q2 Earnings Call Highlights - MarketBeat
Journey Medical Q2 Earnings Call Highlights - MarketBeat
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q2 Earnings - Yahoo Finance
Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Earnings call transcript: Journey Medical tops Q2 2026 forecasts as stock rises - Investing.com
Earnings call transcript: Journey Medical posts Q2 2026 revenue gain, turns EBITDA positive - Investing.com
Earnings call transcript: Journey Medical posts Q2 2026 revenue gain, turns EBITDA positive - Investing.com
Journey Medical earnings beat by $0.12, revenue topped estimates - Investing.com
4.35%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):